Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Immunity”

492 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 492 results

Testing effectiveness (Phase 2)Looking for participantsNCT04150744
What this trial is testing

RFA Plus Carrizumab vs Carrizumab Alone for HCC

Who this might be right for
Tumor ImmunityImmunosuppressionRadiofrequency Ablation
Second Affiliated Hospital, Zhejiang University, School of Medicine 120
Not applicableStudy completedNCT00716911
What this trial is testing

Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
City of Hope Medical Center 100
Testing effectiveness (Phase 2)Looking for participantsNCT06909110
What this trial is testing

Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity

Who this might be right for
AdenovirusCytomegalovirus InfectionsEpstein-Barr Virus Infections
Jessie L. Alexander 25
Not applicableStudy completedNCT02276521
What this trial is testing

Evaluation of Long Term Immunity Following HPV Vaccination

Who this might be right for
Cervical CancerAnogenital Warts
Murdoch Childrens Research Institute 200
Early research (Phase 1)Study completedNCT02947854
What this trial is testing

Study to Assess Safety, Tolerability and Immune Response of Fimaporfin-induced Photochemical Internalisation of Antigen/Adjuvant

Who this might be right for
Healthy Volunteer
PCI Biotech AS 96
Not applicableUnknownNCT03053661
What this trial is testing

Immune Response Evaluation to Curative Conventional Therapy

Who this might be right for
Head and Neck Squamous Cell Carcinoma
University of Ulm 22
Early research (Phase 1)Study completedNCT01826877
What this trial is testing

Autologous Dendritic Cells in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CancerStage IV Renal Cell Cancer
Jonsson Comprehensive Cancer Center 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT03096093
What this trial is testing

Investigation of a Therapeutic Vaccine (ACIT-1) in Cancer

Who this might be right for
CancerNeoplasms
Cancer Vaccines Limited 34
Not applicableLooking for participantsNCT04800393
What this trial is testing

The Impact of Inhalation vs Total Intravenous Anesthesia on the Immune Status and Mortality in Patients Undergoing Breast Cancer Surgery: a Prospective Double-Blind Randomized Clinical Trial.

Who this might be right for
AnesthesiaBreast Cancer
Moscow Clinical Scientific Center 130
Not applicableStudy completedNCT00565305
What this trial is testing

Healing Touch, Quality of Life, and Immunity During Breast Cancer Treatment

Who this might be right for
Breast Cancer
University of Iowa 150
Not applicableEnded earlyNCT01856036
What this trial is testing

Anti-Tumor Immunity Induced by Cryoablation of Invasive Breast Cancers

Who this might be right for
Breast Cancer
Saint John's Cancer Institute 2
Testing effectiveness (Phase 2)Study completedNCT01417000
What this trial is testing

Safety and Efficacy of Combination Listeria/GVAX Immunotherapy in Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Aduro Biotech, Inc. 93
Not applicableStudy completedNCT04647045
What this trial is testing

An Evaluation of Cultured Milk Drink on Immune Status of Patients With Irritable Bowel Syndrome: Constipation Predominant

Who this might be right for
Irritable Bowel Syndrome With Constipation
National University of Malaysia 165
Testing effectiveness (Phase 2)Study completedNCT05683834
What this trial is testing

Trial Evaluating the Immunogenicity and Safety of an Adjuvanted Epstein-Barr Virus (EBV) Glycoprotein 350 Vaccine in EBV-seronegative Persons

Who this might be right for
Epstein-Barr Virus InfectionInfectious MononucleosisHerpesvirus
National Institute of Allergy and Infectious Diseases (NIAID) 25
Testing effectiveness (Phase 2)UnknownNCT00521287
What this trial is testing

Impaired Immunity in Patients With Cancer: Influence of Cancer Stage, Chemotherapy, and Cytomegalovirus Infection

Who this might be right for
Neoplasms
Mackay Memorial Hospital 150
Testing effectiveness (Phase 2)UnknownNCT01626963
What this trial is testing

Single-port Versus Conventional Laparoscopic Colorectal Surgery

Who this might be right for
Colorectal CancerInflammatory Bowel DiseaseBenign Colorectal Neoplasm+1 more
North Tees and Hartlepool NHS Foundation Trust 50
Not applicableUnknownNCT05233358
What this trial is testing

HAIC Combined With Second-line "Target Immunity" for HCC With TACE Standard Treatment Low Response or Failure

Who this might be right for
Hepatocellular Carcinoma
The Central Hospital of Lishui City 176
Not applicableStudy completedNCT01358097
What this trial is testing

Role of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to Therapy

Who this might be right for
Head and Neck CancerOropharyngeal CancerHuman Papillomavirus+1 more
Icahn School of Medicine at Mount Sinai 33
Testing effectiveness (Phase 2)Study completedNCT01867333
What this trial is testing

Enzalutamide With or Without Vaccine Therapy for Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 57
Not applicableStudy completedNCT00001158
What this trial is testing

Studies of the Immune Response in Normal Subjects and Patients With Disorders of the Immune System

Who this might be right for
Immunologic Deficiency SyndromesNeoplasms
National Cancer Institute (NCI)
Next Page